CRON | Cronos Group Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.8600 - 1.9700
52 Week Range	1.8600 - 3.14
Beta	0.97
Implied Volatility	64.18%
IV Rank	48.87%
Day's Volume	1,898,349
Average Volume	1,069,071
Shares Outstanding	382,295,000
Market Cap	745,475,250
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2018-02-27

Valuation
Profitability
Growth
Health
P/E Ratio	-16.25
Forward P/E Ratio	-14.92
EPS	-0.12
1YR Price Target	2.99
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	356
Country	Canada
Website	CRON

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

CRON's peers: ACB, OGI, SNDL, CGC, TLRY, HEXO, CURLF, ZOM, TEVA

*Chart delayed

Analyzing fundamentals for CRON we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is good and Health is passable. For more detailed analysis please see CRON Fundamentals page.

Watching at CRON technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CRON Technicals page.